FDA Approves Extended-Release Injection for Opioid Use Disorder
Lori Solomon
TUESDAY, May 30, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat moderate-to-severe opioid…